As the public health response to COVID-19, the illness caused by the novel coronavirus, continues to evolve, we plan to keep you informed of any related temporary changes in our policies, procedures and practices.
With an increasing number of people in or near our service areas diagnosed with COVID-19, the illness caused by the novel coronavirus, we’re working closely with local, state and federal health partners to keep you informed. We’re here to help you and your employees understand the guidance that public health officials are providing, and to answer all questions about your plan’s coverage during this ongoing situation.
Health Alliance announced today that it will waive cost sharing for COVID-19 testing for members of all group and individual fully-insured plans in all states, as well as members in all Medicare Advantage Plans and the Federal Employees Health Benefits (FEHB) Plan. Health Alliance will cover, with no member cost share, the appropriate medically necessary diagnostic testing for COVID-19, where it is not covered as part of the Public Health Service response. At this time, the Centers for Disease Control and Prevention (CDC) continues to pay for the laboratory tests.
Today all of our members received the following email, which contained information and updates about coronavirus (COVID-19):
Health Alliance has a responsibility to be a good steward of members’ and employers’ premium dollars. Starting June 1, 2020, Health Alliance is implementing a provider policy governing how Health Alliance contracted providers serving our fully insured commercial group and individual members and many Health Alliance self-funded plans must acquire high cost medical drugs prescribed for our members. This is not a member policy.